Selective EP4 receptor antagonistic substance for treatment of cancer Grant US-11840530-B2 United States of America 12 Dec 2023
Selective EP4 receptor antagonistic substance for treatment of cancer Grant US-10947235-B2 United States of America 16 Mar 2021
Selective EP4 receptor antagonistic substance for treatment of cancer Grant US-10611761-B2 United States of America 07 Apr 2020
CXCL12 (CHEMOKINE (C-X-C MOTIF) LIGAND 12) AND IGFBP2 INHIBITORS FOR THE APPLICATION IN… Application WO-2015028831-A1 World Intellectual Property Organisation (WIPO) 05 Mar 2015